Advertisement

Topics

ReNeuron Group plc Company Profile

05:39 EDT 22nd June 2018 | BioPortfolio

ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our stem cell technologies into non-therapeutic areas such as drug discovery - our ReNcell product.We have proprietary stem cell technologies which we believe confer significant advantages over competitor technologies, in terms of our ability to generate stable cell lines with the characteristics necessary for commercial exploitation

Location

10 Nugent Rd Surrey Research Park
Guildford,
Surrey
GU2 7AF
United Kingdom

Contact

Phone: 44 (0)1483 302560
Fax: 44 (0)1483 534864
Email: info@reneuron.com


News Articles [415 Associated News Articles listed on BioPortfolio]

ReNeuron Group (RENE) - The rise of the exosome

Edison Investment Research - Pharmaceutical & healthcare - ReNeuron Group: ReNeuron introduced its exosome nanomedicine programme at its recent capital markets day. While being a preclinical programme...

ReNeuron Group (RENE) - Consolidation confusion?

Edison Investment Research - Pharmaceutical & healthcare - ReNeuron Group: ReNeuron’s recent 100 for 1 share consolidation was a benign and cosmetic ‘tidy up’ of its historical capit...

ReNeuron pleased to secure podium presentation for stroke data at US conference

Michael Hunt, CFO at ReNeuron Group Plc (LON:RENE) tells Proactive positive long-term data on their CTX cell therapy for stroke has been presented at the American Heart Association International Str...

ReNeuron's Michael Hunt updates on product development

Michael Hunt, CFO at ReNeuron Group Plc (LON:RENE) chats to Proactive to update on the cell-based therapeutics specialist's research and development programmes. Hunt says they're to increase the n...

ReNeuron presents positive data for CTX cell therapy candidate

Cell-based therapeutics developer ReNeuron Group announced on Friday that positive long-term data from the Phase II clinical trial - PISCES II -of its CTX cell therapy candidate for stroke disabili...

BRIEF—ReNeuron appoints new chief medical officer

UK cell-based therapies company ReNeuron today announced that Dr Richard Beckman has joined the company…

ReNeuron's Michael Hunt discusses very encouraging long-term stroke data

Michael Hunt, chief financial officer at ReNeuron Group Plc (LON:RENE) updates Proactive on their phase II clinical study treating stroke patients with its CTX stem cells. Hunt says the positive r...

ReNeuron wins grant to advance development of stem cell therapy

UK-based developer of cell-based therapeutics, ReNeuron Group, has won a grant to advance the development of its hRPC stem cell therapy candidate for blindness-causing degenerative diseases of the ret...

PubMed Articles [1804 Associated PubMed Articles listed on BioPortfolio]

Group Influences on Engaging Self-Control: Children Delay Gratification and Value It More When Their In-Group Delays and Their Out-Group Doesn't.

Self-control emerges in a rich sociocultural context. Do group norms around self-control influence the degree to which children use it? We tested this possibility by assigning 3- to 5-year-old childre...

An Examination of Group Size and Valence in Delay Discounting of Shared Outcomes.

Previous research has examined delay discounting in a group context, where the outcomes are shared with others. These studies indicate shallow delay discounting in a group context compared to an indiv...

Ameliorating effects of tempol on methotrexate-induced liver injury in rats.

Methotrexate (MTX) is used in the treatment of certain types of cancers and chronic inflammatory illnesses, although the clinical use of MTX is limited due to its adverse effects, the most common of w...

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

Medulloblastoma, the most common malignant pediatric brain tumor, is a heterogeneous disease, with the existence of at least four molecular types: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Gro...

Nephroprotective Effect of Zingerone against CCl-Induced Renal Toxicity in Swiss Albino Mice: Molecular Mechanism.

The protective effects of Zingerone against CCl induced nephrotoxicity in Swiss albino mice via modulation of metabolizing enzyme, oxidative stress, inflammatory cytokines, and apoptosis. The biochemi...

Clinical Trials [3703 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

the Influence of Sleep Improvement Through Different Methods on Patients in ICU

In the research, we enroll 120 postoperative patients in the ICU and they will be assigned to four group: the eye patch group, the Dexmedetomidine(DEX) group, the eye patch+DEX group and t...

Companies [1617 Associated Companies listed on BioPortfolio]

ReNeuron

ReNeuron stem cell transplantation biotechnology for brain cell therapeutics to promote recovery of function.

ReNeuron Group plc

ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our ste...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

ACE Group

Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...

More Information about "ReNeuron Group plc" on BioPortfolio

We have published hundreds of ReNeuron Group plc news stories on BioPortfolio along with dozens of ReNeuron Group plc Clinical Trials and PubMed Articles about ReNeuron Group plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ReNeuron Group plc Companies in our database. You can also find out about relevant ReNeuron Group plc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record